Table 3. Global changes in histone methylation marks have been reported in various types of cancers.
Correlative studies report altered histone methylation patterns in specific cancer types189–197. In some of these cases multiple methyl marks have been shown to change in concert highlighting the importance of combinatorial modifications effect on biological functions.
| Cancer type | Methyl mark | Consequence | Reference |
|---|---|---|---|
| Prostate cancer | ↓ H3K4me2 | Higher recurrence | 1 |
| ↓ H4R2me2 | Higher recurrence | 1 | |
| Lung cancer | ↓ H3K4me2 | Poorer survival | 2, 3 |
| Kidney cancer | ↓ H3K4me2 | Poorer survival | 3 |
| Breast cancer | ↓ H3K4me2 | Poorer survival | 5 |
| ↓ H3K27me3 | Poorer survival | 7 | |
| ↓ H4R3me2 | Worse clinical outcomes | 5 | |
| ↓ H4K20me3 | Worse clinical outcomes | 5 | |
| Pancreatic cancer | ↓ H3K4me2 | Poorer survival | 4 |
| ↓ H3K9me2 | Poorer survival | 4 | |
| ↓ H3K27me3 | Poorer survival | 7 | |
| Gastric adenocarcinoma | ↑ H3K9me3 | Poorer survival | 6 |
| Ovarian cancer | ↓ H3K27me3 | Poorer survival | 7 |
| Lymphomas | ↓ H4K20me3 | Associated with | 8 |
| Colon adenocarcinomas | ↓ H4K20me3 | Associated with | 8 |